{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:27:29Z","timestamp":1770755249809,"version":"3.50.0"},"reference-count":27,"publisher":"Japanese Association of Rural Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rural Med"],"published-print":{"date-parts":[[2023]]},"DOI":"10.2185\/jrm.2023-008","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T22:55:51Z","timestamp":1696114551000},"page":"215-221","source":"Crossref","is-referenced-by-count":2,"title":["Uptake and impact of COVID-19 vaccination among HIV key populations: a cohort          study from Tamil Nadu, India"],"prefix":"10.2185","volume":"18","author":[{"given":"M","family":"Saleem","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Government Dindigul              Medical College, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janakiram","family":"Marimuthu","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Government Vellore              Medical College, India"},{"name":"Targeted Intervention and Strategic Information              Management Unit, Tamil Nadu AIDS Control Society, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aravind P","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College              &amp; Hospital, Hyderabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"995","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Watson              OJ, Barnsley              G, Toor              J, et al.            Global impact of the first year of COVID-19 vaccination: a mathematical            modelling study. Lancet Infect Dis          2022; 22: 1293\u20131302.","DOI":"10.1016\/S1473-3099(22)00320-6"},{"key":"2","unstructured":"2. Anon.            . (Accessed September, 2022)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Thomas              B, Mimiaga              MJ, Kumar              S, et al.            HIV in Indian MSM: reasons for a concentrated epidemic &amp; strategies            for prevention. Indian J Med Res          2011; 134: 920\u2013929.","DOI":"10.4103\/0971-5916.92637"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mahapatra              B,                Bhattacharya              R, Atmavilas              Y, et al.            Measuring vulnerability among female sex workers in India using a            multidimensional framework. PLoS One          2018; 13: e0204055.","DOI":"10.1371\/journal.pone.0204055"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Harner              V, Munion              AK, Shelton              J. Trans adults            amidst the COVID-19 pandemic: quality of life, pandemic impact, and vaccine            preferences. Int J Environ Res Public Health          2021; 18: 12536.","DOI":"10.3390\/ijerph182312536"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garg              I, Hanif              H, Javed              N, et al.            COVID-19 vaccine hesitancy in the LGBTQ+ population: a systematic            review. Infect Dis Rep          2021; 13: 872\u2013887.","DOI":"10.3390\/idr13040079"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Goldie              PD,                Chatterjee              I. Examining            the elevated risk of COVID-19 in transgender communities with an intersectional            lens. SN Soc Sci          2021; 1: 249.","DOI":"10.1007\/s43545-021-00255-x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Azucar              D, Slay              L, Valerio              DG, et al.            Barriers to COVID-19 vaccine uptake in the LGBTQIA            community. Am J Public Health          2022; 112: 405\u2013407.","DOI":"10.2105\/AJPH.2021.306599"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Teixeira da                Silva              D, Biello              K, Lin              WY, et al.            COVID-19 Vaccine acceptance among an online sample of sexual and gender            minority men and transgender women. Vaccines (Basel)          2021; 9: 1\u201310.","DOI":"10.3390\/vaccines9030204"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. McNaghten              AD, Brewer              NT, Hung              MC, et al.            COVID-19 vaccination coverage and vaccine confidence by sexual            orientation and gender identity\u2014United States, August 29\u2013October 30,            2021. MMWR Morb Mortal Wkly Rep          2022; 71: 171\u2013176.","DOI":"10.15585\/mmwr.mm7105a3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Low              A, Wright              C, Platt              J, et al.            COVID-19 vaccine uptake and factors associated with being unvaccinated            among lesbian, gay, bisexual, transgender, queer, and other sexual identities (LGBTQ+)            New Yorkers. Open Forum Infect Dis          2022; 9: ofac260.","DOI":"10.1093\/ofid\/ofac260"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zheng              W, Sun              Y, Li              H, et al.            COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex            with men in mainland China: a cross-sectional survey. Hum Vaccin            Immunother          2021; 17: 4971\u20134981.","DOI":"10.1080\/21645515.2021.1996152"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kumar              P, Das              C, Kumar              A, et al.            Diversity in HIV epidemic transitions in India: an application of HIV            epidemiological metrices and benchmarks. PLoS One          2022; 17: e0270886.","DOI":"10.1371\/journal.pone.0270886"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lopez                Bernal              J, Andrews              N, Gower              C, et al.            Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta)            variant. N Engl J Med          2021; 385: 585\u2013594.","DOI":"10.1056\/NEJMoa2108891"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Das              S, Kar              SS, Samanta              S, et al.            Immunogenic and reactogenic efficacy of Covaxin and Covishield: a            comparative review. Immunol Res          2022; 70: 289\u2013315.","DOI":"10.1007\/s12026-022-09265-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ghosh              S, Shankar              S, Chatterjee              K, et al.            COVISHIELD (AZD1222) VaccINe effectiveness among healthcare and frontline            Workers of Indian Armed Forces: Interim results of VIN-WIN cohort study.            Med J Armed Forces India          2021; 77(Suppl 2):            S264\u2013S270.","DOI":"10.1016\/j.mjafi.2021.06.032"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Holt              M, MacGibbon              J, Bavinton              B, et al.            COVID-19 vaccination uptake and hesitancy in a national sample of            Australian gay and bisexual men. AIDS Behav          2022; 26: 2531\u20132538.","DOI":"10.1007\/s10461-022-03603-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Prestage              G, Storer              D, Jin              F, et al.            COVID-19\u00a0vaccine\u00a0uptake and its impacts in a cohort of\u00a0gay and\u00a0bisexual            men\u00a0in Australia. AIDS Behav          2022; 26: 2692\u20132702.","DOI":"10.1007\/s10461-022-03611-x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Murali              S, Sakthivel              M, Pattabi              K, et al.            Effectiveness of the ChAdOx1 nCoV-19 coronavirus vaccine              (Covishield<sup>TM<\/sup>) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu,            India, 2021. Vaccines (Basel)          2022; 10: 970.","DOI":"10.3390\/vaccines10060970"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Arora              G, Taneja              J, Bhardwaj              P, et al.            Adverse events and breakthrough infections associated with COVID-19            vaccination in the Indian population. J Med Virol          2022; 94: 3147\u20133154.","DOI":"10.1002\/jmv.27708"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dhumal              S, Patil              A, More              A, et al.            SARS-CoV-2 reinfection after previous infection and vaccine breakthrough            infection through the second wave of pandemic in India: an observational            study. Int J Infect Dis          2022; 118: 95\u2013103.","DOI":"10.1016\/j.ijid.2022.02.037"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gandhi              AP, Thakur              JS, Gupta              M, et al.            COVID-19 vaccination uptake and adverse events following COVID-19            immunization in pregnant women in Northern India: a prospective, comparative, cohort            study. J Rural Med          2022; 17: 228\u2013235.","DOI":"10.2185\/jrm.2022-025"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schmaling              KB. Couples and            COVID-19 vaccination: frequency and reasons for discordance.            Vaccine          2022; 40: 1913\u20131917.","DOI":"10.1016\/j.vaccine.2022.02.055"},{"key":"24","unstructured":"24. Frater              J, Ewer              KJ, Ogbe              A, et al.            Oxford COVID Vaccine Trial Group.Safety and            immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV            infection: a single-arm substudy of a phase 2\/3 clinical trial.            Lancet HIV          2021; 8: e474\u2013e485."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zou              S, Wu              M, Ming              F, et al.            Immune response and safety to inactivated COVID-19 vaccine: a comparison            between people living with HIV and HIV-naive individuals. AIDS            Res Ther          2022; 19: 33.","DOI":"10.1186\/s12981-022-00459-y"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Oyelade              T, Raya              RP, Latief              K. HIV            infection and the implication for COVID-19 vaccination. Public            Health Chall          2022; 1: e14.","DOI":"10.1002\/puh2.14"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Heslin              KC, Hall              JE. Sexual            orientation disparities in risk factors for adverse COVID-19-related outcomes, by            race\/ethnicity\u2014behavioral risk factor surveillance system, United States,            2017\u20132019. MMWR Morb Mortal Wkly Rep          2021; 70: 149\u2013154.","DOI":"10.15585\/mmwr.mm7005a1"}],"container-title":["Journal of Rural Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jrm\/18\/4\/18_2023-008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:19:21Z","timestamp":1715577561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jrm\/18\/4\/18_2023-008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2185\/jrm.2023-008","relation":{},"ISSN":["1880-487X","1880-4888"],"issn-type":[{"value":"1880-487X","type":"print"},{"value":"1880-4888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2023-008"}}